Literature DB >> 26839091

Evaluation of the glucocorticoid, mineralocorticoid, and adrenal androgen secretion dynamics in a large cohort of patients aged 6-18 years with transfusion-dependent β-thalassemia major, with an emphasis on the impact of cardiac iron load.

Ahmet Uçar1, Nergiz Öner2, Gülcihan Özek2, Mehmet Güli Çetinçakmak3, Mahmut Abuhandan4, Ali Yıldırım5, Cemil Kaya6, Sena Ünverdi7, Hamdi Cihan Emeksiz8, Yasin Yılmaz9, Aylin Yetim10.   

Abstract

The variable presence of adrenal insufficiency (AI) due to hypocortisolemia (HC) in patients with thalassemia is well established; however, the prevalence of adrenocortical hypofunction (ACH) in the zona glomerulosa and zona reticularis of the adrenal cortex is unknown. To establish the prevalence of ACH, we examined the cortisol response to 1-µg and 250-µg ACTH tests, plasma aldosterone (A)/plasma renin activity (PRA) ratio, and serum dehydroepiandrosterone sulfate (DHEAS) levels in a large cohort of patients with thalassemia, and to investigate the impact of total body iron load (TBIL) on adrenocortical function. The setting used was University hospital and government-based tertiary care center. One hundred twenty-one (52 females) patients with β-thalassemia major (β-TM) and 72 healthy peers (38 females) were enrolled. The patients underwent a 250-µg cosyntropin test if their peak cortisol was <500 nmol/L in a 1-µg cosyntropin test. Magnetic resonance imaging (MRI) was performed to assess the MRI-based liver iron content and cardiac MRI T2* iron. The associations between ACH and TBIL were investigated. The patients with thalassemia had lower ACTH, cortisol, DHEAS, and A/PRA values compared with the controls (p < 0.001). Thirty-nine patients (32.2 %) had HC [primary (n = 1), central (n = 36), combined (n = 2)], and 47 (38.8 %) patients had reduced DHEAS levels; 29 (24.0 %) patients had reduced A/PRA ratios. Forty-six (38.0 %) patients had hypofunction in one of the adrenal zones, 26 (21.5 %) had hypofunction in two adrenal zones, and 9 (7.4 %) had hypofunction in all three zones. Patient age and TBIL surrogates were significant independent parameters associated with ACH. Cardiac MRI T2* iron was the only significant parameter that predicted the severity of ACH at a cut-off of 20.6 ms, with 81 % sensitivity and 78 % specificity. Patients with thalassemia have a high prevalence of AI due to HC and zona glomerulosa and zona reticularis hypofunction. TBIL surrogates can predict ACH, but cardiac iron was the only surrogate that was adequately sensitive to predict the severity of ACH.

Entities:  

Keywords:  Adrenocortical; Cardiac MRI T2* iron; Cortisol; Dehydroepiandrosterone sulfate; Mineralocorticoid; Thalassemia major; Total body iron load

Mesh:

Substances:

Year:  2016        PMID: 26839091     DOI: 10.1007/s12020-016-0872-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Prevalence of β-thalassemia trait and abnormal hemoglobins in Sanliurfa Province in southeast Turkey.

Authors:  Adnan Incebiyik; Ahmet Genc; Nese Gul Hilali; Aysun Camuzcuoglu; Hakan Camuzcuoglu; Avni Kilic; Mehmet Vural
Journal:  Hemoglobin       Date:  2014       Impact factor: 0.849

3.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.

Authors:  G B Gordon; D E Bush; H F Weisman
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

Review 5.  Endocrine gland abnormalities in thalassemia major: a brief review.

Authors:  Sakineh Mohammadian; Hamid Reza Bazrafshan; Ab Sadeghi-Nejad
Journal:  J Pediatr Endocrinol Metab       Date:  2003-09       Impact factor: 1.634

6.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

7.  A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.

Authors:  Karen E Huang; Steven D Mittelman; Thomas D Coates; Mitchell E Geffner; John C Wood
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

8.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06

9.  Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major.

Authors:  Ashraf T Soliman; Mohamed Yassin; Nadra M S Abdel Majuid; Aml Sabt; Mohamed O Abdulrahman; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-11

Review 10.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21
View more
  4 in total

1.  The Diagnostic Approach to Central Adrenocortical Insufficiency (CAI) in Thalassemia.

Authors:  Vincenzo De Sanctis; Heba Elsedfy; Ashraf T Soliman; Ihab Zaki Elhakim; Nada A Soliman; Mehran Karimi; Rania Elalaily
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-05-01       Impact factor: 2.576

2.  Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.

Authors:  Alberto G Ambrogio; Leila Danesi; Marina Baldini; Raffaella Radin; Elena Cassinerio; Giovanna Graziadei; Nadia Mirra; Emanuela D'Angelo; Alessia Marcon; Marta Mancarella; Alessandra Orsatti; Federico Bonetti; Massimo Scacchi; Maria Domenica Cappellini; Luca Persani; Francesca Pecori Giraldi
Journal:  Endocrine       Date:  2018-03-23       Impact factor: 3.633

3.  An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Duran Canatan; Ploutarchos Tzoulis; Shahina Daar; Salvatore Di Maio; Heba Elsedfy; Mohamed A Yassin; Aldo Filosa; Nada Soliman; Karimi Mehran; Forough Saki; Praveen Sobti; Shruti Kakkar; Soteroula Christou; Alice Albu; Constantinos Christodoulides; Yurdanur Kilinc; Soad Al Jaouni; Doaa Khater; Saif A Alyaarubi; Su Han Lum; Saveria Campisi; Salvatore Anastasi; Maria Concetta Galati; Giuseppe Raiola; Yasser Wali; Ihab Z Elhakim; Demetris Mariannis; Vassilis Ladis; Christos Kattamis
Journal:  Acta Biomed       Date:  2019-01-15

4.  New Insights and Methods in the Approach to Thalassemia Major: The Lesson From the Case of Adrenal Insufficiency.

Authors:  Maurizio Poggi; Irene Samperi; Lorenza Mattia; Arianna Di Rocco; Cristina Iorio; Salvatore Monti; Giuseppe Pugliese; Vincenzo Toscano
Journal:  Front Mol Biosci       Date:  2020-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.